Fair Value Measurements (excluding Consolidated Investment Entities) (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
| Fair Value Disclosures [Abstract] |
|
| Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis |
The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of March 31, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | Level 1 | | Level 2 | | Level 3 | | Total | | Assets: | | | | | | | | Fixed maturities, including securities pledged: | | | | | | | | U.S. Treasuries | $ | 503 | | | $ | 125 | | | $ | — | | | $ | 628 | | U.S. Government agencies and authorities | — | | | 31 | | | — | | | 31 | | State, municipalities and political subdivisions | — | | | 464 | | | — | | | 464 | | | U.S. corporate public securities | — | | | 7,848 | | | 77 | | | 7,925 | | | U.S. corporate private securities | — | | | 3,198 | | | 2,306 | | | 5,504 | | Foreign corporate public securities and foreign governments(1) | — | | | 2,617 | | | 59 | | | 2,676 | | Foreign corporate private securities(1) | — | | | 2,112 | | | 740 | | | 2,852 | | | Residential mortgage-backed securities | — | | | 4,097 | | | 75 | | | 4,172 | | | Commercial mortgage-backed securities | — | | | 2,484 | | | — | | | 2,484 | | | Other asset-backed securities | — | | | 2,497 | | | 318 | | | 2,815 | | Total fixed maturities, including securities pledged | 503 | | | 25,473 | | | 3,575 | | | 29,551 | | Equity securities | 110 | | | — | | | 83 | | | 193 | | | Derivatives: | | | | | | | | | Interest rate contracts | — | | | 185 | | | — | | | 185 | | | Foreign exchange contracts | — | | | 17 | | | — | | | 17 | | | Equity contracts | — | | | 1 | | | — | | | 1 | | Embedded derivatives within reinsurance | — | | | 46 | | | — | | | 46 | | | Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements | 2,183 | | | 8 | | | — | | | 2,191 | | | Assets held in separate accounts | 102,819 | | | 5,222 | | | 426 | | | 108,467 | | | Total assets | $ | 105,615 | | | $ | 30,952 | | | $ | 4,084 | | | $ | 140,651 | | | Liabilities: | | | | | | | | | Contingent consideration | $ | — | | | $ | — | | | $ | 22 | | | $ | 22 | | | Stabilizer and MCGs | — | | | — | | | 7 | | | 7 | | | Derivatives: | | | | | | | | | Interest rate contracts | 5 | | | 239 | | | — | | | 244 | | | Foreign exchange contracts | — | | | 15 | | | — | | | 15 | | | Equity contracts | — | | | 3 | | | — | | | 3 | | | | | | | | | | Embedded derivatives within reinsurance | — | | | (9) | | (2) | — | | | (9) | | | Total liabilities | $ | 5 | | | $ | 248 | | | $ | 29 | | | $ | 282 | |
(1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within the liabilities section as the balance represents an offset to a funds withheld liability. The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | Level 1 | | Level 2 | | Level 3 | | Total | | Assets: | | | | | | | | | Fixed maturities, including securities pledged: | | | | | | | | | U.S. Treasuries | $ | 486 | | | $ | 128 | | | $ | — | | | $ | 614 | | | U.S. Government agencies and authorities | — | | | 31 | | | — | | | 31 | | | State, municipalities and political subdivisions | — | | | 510 | | | — | | | 510 | | | U.S. corporate public securities | — | | | 7,786 | | | 78 | | | 7,864 | | | U.S. corporate private securities | — | | | 3,522 | | | 2,100 | | | 5,622 | | Foreign corporate public securities and foreign governments(1) | — | | | 2,718 | | | 60 | | | 2,778 | | Foreign corporate private securities(1) | — | | | 2,178 | | | 631 | | | 2,809 | | | Residential mortgage-backed securities | — | | | 4,273 | | | 71 | | | 4,344 | | | Commercial mortgage-backed securities | — | | | 2,676 | | | — | | | 2,676 | | | Other asset-backed securities | — | | | 2,604 | | | 299 | | | 2,903 | | | Total fixed maturities, including securities pledged | 486 | | | 26,426 | | | 3,239 | | | 30,151 | | Equity securities | 107 | | | — | | | 94 | | | 201 | | | Derivatives: | | | | | | | | | Interest rate contracts | 2 | | | 182 | | | — | | | 184 | | | Foreign exchange contracts | — | | | 10 | | | — | | | 10 | | | Equity contracts | — | | | 3 | | | — | | | 3 | | Embedded derivatives within reinsurance | — | | | 55 | | | — | | | 55 | | | Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements | 2,352 | | | 5 | | | — | | | 2,357 | | | Assets held in separate accounts | 107,191 | | | 5,428 | | | 388 | | | 113,007 | | | Total assets | $ | 110,138 | | | $ | 32,109 | | | $ | 3,721 | | | $ | 145,968 | | | Liabilities: | | | | | | | | | Contingent consideration | $ | — | | | $ | — | | | $ | 147 | | | $ | 147 | | | Stabilizer and MCGs | — | | | — | | | 5 | | | 5 | | | Derivatives: | | | | | | | | | Interest rate contracts | — | | | 258 | | | — | | | 258 | | | Foreign exchange contracts | — | | | 22 | | | — | | | 22 | | | Equity contracts | — | | | 2 | | | — | | | 2 | | | | | | | | | | Embedded derivatives within reinsurance | — | | | (9) | | (2) | — | | | (9) | | | Total liabilities | $ | — | | | $ | 273 | | | $ | 152 | | | $ | 425 | |
(1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within the liabilities section as the balance represents an offset to a funds withheld liability.
|
| Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation |
The following tables summarize the change in fair value of the Company's Level 3 assets and liabilities and transfers in and out of Level 3 for the periods indicated:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2026 | | Fair Value as of January 1 | | Realized/Unrealized Gains (Losses) Included in: | | Purchases | | Issuances | | Sales | | Settlements
| | Transfers into Level 3 | | Transfers out of Level 3 | | Fair Value as of March 31 | | Change In Unrealized Gains (Losses) Included in Earnings(3) | | Change In Unrealized Gains (Losses) Included in OCI(3) | | | Net income | | OCI | | | | | | | | | | | Fixed maturities, including securities pledged: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | U.S. corporate public securities | $ | 78 | | | $ | — | | | $ | (1) | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | 77 | | | $ | — | | | $ | (1) | | | U.S. corporate private securities | 2,100 | | | (3) | | | (27) | | | 283 | | | — | | | (41) | | | (101) | | | 120 | | | (25) | | | 2,306 | | | — | | | (27) | | Foreign corporate public securities and foreign governments(1) | 60 | | | — | | | (1) | | | — | | | — | | | — | | | — | | | — | | | — | | | 59 | | | — | | | (1) | | Foreign corporate private securities(1) | 631 | | | (1) | | | (6) | | | 124 | | | — | | | — | | | (8) | | | — | | | — | | | 740 | | | — | | | (7) | | | Residential mortgage-backed securities | 71 | | | (2) | | | — | | | 11 | | | — | | | — | | | — | | | — | | | (5) | | | 75 | | | (2) | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | Other asset-backed securities | 299 | | | — | | | 1 | | | 78 | | | — | | | (2) | | | (14) | | | — | | | (44) | | | 318 | | | — | | | 1 | | | Total fixed maturities, including securities pledged | 3,239 | | | (6) | | | (34) | | | 496 | | | — | | | (43) | | | (123) | | | 120 | | | (74) | | | 3,575 | | | (2) | | | (35) | | | | | | | | | | | | | | | | | | | | | | | | | | Equity securities, at fair value | 94 | | | — | | | — | | | — | | | — | | | (11) | | | — | | | — | | | — | | | 83 | | | — | | | — | | | Contingent consideration | (147) | | | (4) | | | — | | | — | | | — | | | — | | | 129 | | | — | | | — | | | (22) | | | — | | | — | | Stabilizer and MCGs(2) | (5) | | | (2) | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (7) | | | — | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Assets held in separate accounts(4) | 388 | | | (4) | | | — | | | 38 | | | — | | | (7) | | | — | | | 12 | | | (1) | | | 426 | | | — | | | — | |
(1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract-by-contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of March 31, amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on investments in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income for the Company.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2025 | | Fair Value as of January 1 | | Realized/Unrealized Gains (Losses) Included in: | | Purchases | | Issuances | | Sales | | Settlements
| | Transfers into Level 3 | | Transfers out of Level 3 | | Fair Value as of March 31 | | Change In Unrealized Gains (Losses) Included in Earnings(3) | | Change In Unrealized Gains (Losses) Included in OCI(3) | | | Net income | | OCI | | | | | | | | | | | Fixed maturities, including securities pledged: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | U.S. corporate public securities | $ | 59 | | | $ | (1) | | | $ | 2 | | | $ | 1 | | | $ | — | | | $ | (11) | | | $ | — | | | $ | — | | | $ | (2) | | | $ | 48 | | | $ | — | | | $ | — | | | U.S. corporate private securities | 1,497 | | | (1) | | | 19 | | | 194 | | | — | | | (7) | | | (25) | | | — | | | — | | | 1,677 | | | — | | | 19 | | Foreign corporate public securities and foreign governments(1) | 60 | | | — | | | (1) | | | — | | | — | | | — | | | — | | | — | | | — | | | 59 | | | — | | | (1) | | Foreign corporate private securities(1) | 421 | | | (19) | | | 29 | | | 161 | | | — | | | — | | | (2) | | | — | | | — | | | 590 | | | (19) | | | 29 | | | Residential mortgage-backed securities | 67 | | | (3) | | | — | | | 16 | | | — | | | — | | | — | | | — | | | (10) | | | 70 | | | (3) | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | Other asset-backed securities | 23 | | | — | | | — | | | 3 | | | — | | | — | | | (3) | | | — | | | (4) | | | 19 | | | — | | | — | | | Total fixed maturities, including securities pledged | 2,127 | | | (24) | | | 49 | | | 375 | | | — | | | (18) | | | (30) | | | — | | | (16) | | | 2,463 | | | (22) | | | 47 | | | | | | | | | | | | | | | | | | | | | | | | | | Equity securities, at fair value | 98 | | | 3 | | | — | | | 9 | | | — | | | — | | | — | | | — | | | — | | | 110 | | | 3 | | | — | | | Contingent consideration | (2) | | | (2) | | | — | | | — | | | (149) | | (5) | — | | | 1 | | | — | | | — | | | (152) | | | — | | | — | | Stabilizer and MCGs(2) | (19) | | | 3 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (16) | | | — | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | Embedded derivatives within reinsurance | (53) | | | 1 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (52) | | | — | | | — | | | Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements | 23 | | | — | | | 1 | | | — | | | — | | | — | | | — | | | — | | | — | | | 24 | | | — | | | 1 | | Assets held in separate accounts(4) | 340 | | | 4 | | | — | | | 8 | | | — | | | (14) | | | — | | | — | | | — | | | 338 | | | — | | | — | |
(1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of March 31, amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on investments in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income for the Company. (5) Represents a portion of the purchase consideration related to the acquisition of OneAmerica Financial's full-service retirement plan business.
|
| Fair Value, by Balance Sheet Grouping |
The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated:
| | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2026 | | December 31, 2025 | | Carrying Value | | Fair Value | | Carrying Value | | Fair Value | | Assets: | | | | | | | | | Fixed maturities, including securities pledged | $ | 29,551 | | | $ | 29,551 | | | $ | 30,151 | | | $ | 30,151 | | | Equity securities | 193 | | | 193 | | | 201 | | | 201 | | | Mortgage loans on real estate | 5,664 | | | 5,524 | | | 5,608 | | | 5,522 | | | Policy loans | 316 | | | 316 | | | 323 | | | 323 | | | Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements | 2,191 | | | 2,191 | | | 2,357 | | | 2,357 | | | Derivatives | 203 | | | 203 | | | 197 | | | 197 | | Embedded derivatives within reinsurance | 46 | | | 46 | | | 55 | | | 55 | | | | | | | | | | Other investments | 90 | | | 90 | | | 86 | | | 86 | | | Assets held in separate accounts | 108,467 | | | 108,467 | | | 113,007 | | | 113,007 | | | Liabilities: | | | | | | | | | Investment contract liabilities: | | | | | | | | Funding agreements without fixed maturities and deferred annuities(1) | $ | 33,570 | | | $ | 36,578 | | | $ | 33,793 | | | $ | 37,154 | | | Funding agreements with fixed maturities | 2,256 | | | 2,276 | | | 2,101 | | | 2,120 | | Supplementary contracts and immediate annuities | 501 | | | 483 | | | 504 | | | 481 | | | | | | | | | | | Stabilizer and MCGs | 7 | | | 7 | | | 5 | | | 5 | | | Derivatives | 262 | | | 262 | | | 282 | | | 282 | | Embedded derivatives within reinsurance(2) | (9) | | | (9) | | | (9) | | | (9) | | | Short-term debt | 587 | | | 587 | | | 586 | | | 588 | | | Long-term debt | 1,913 | | | 1,826 | | | 1,518 | | | 1,489 | |
(1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within Stabilizer and MCGs. (2) The Company classifies the embedded derivative within the liabilities section as the balance represents an offset to a funds withheld liability. The following table shows the fair value hierarchy for assets and liabilities measured on a recurring basis within the Company's consolidated investment entities as of March 31, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Level 1 | | Level 2 | | Level 3 | | NAV | | Total | | Assets | | | | | | | | | | | VIEs | | | | | | | | | | Cash and cash equivalents | $ | 118 | | | $ | — | | | $ | — | | | $ | — | | | $ | 118 | | | Corporate loans | — | | | 1,488 | | | — | | | — | | | 1,488 | | | Limited partnerships/corporations | — | | | — | | | — | | | 2,971 | | | 2,971 | | Other investments(1) | — | | | — | | | 66 | | | — | | | 66 | | VOEs | | | | | | | | | | | Cash and cash equivalents | 3 | | | — | | | — | | | — | | | 3 | | | | | | | | | | | | Other investments(1) | — | | | — | | | — | | | 20 | | | 20 | | | | | | | | | | | | | Total assets | $ | 121 | | | $ | 1,488 | | | $ | 66 | | | $ | 2,991 | | | $ | 4,666 | | | Liabilities | | | | | | | | | | | VIEs | | | | | | | | | | | CLO notes | $ | — | | | $ | 1,173 | | | $ | — | | | $ | — | | | $ | 1,173 | | | Total liabilities | $ | — | | | $ | 1,173 | | | $ | — | | | $ | — | | | $ | 1,173 | | |
(1) VIEs and VOEs - Other investments are reflected in Assets related to consolidated investment entities - Other assets on the Company's Condensed Consolidated Balance Sheets.
The following table shows the fair value for assets and liabilities measured on a recurring basis within the Company's consolidated investment entities as of December 31, 2025:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Level 1 | | Level 2 | | Level 3 | | NAV | | Total | | Assets | | | | | | | | | | | VIEs | | | | | | | | | | | Cash and cash equivalents | $ | 116 | | | $ | — | | | $ | — | | | $ | — | | | $ | 116 | | | Corporate loans | — | | | 1,350 | | | — | | | — | | | 1,350 | | | Limited partnerships/corporations | — | | | — | | | — | | | 3,142 | | | 3,142 | | Other investments(1) | — | | | — | | | 43 | | | — | | | 43 | | | VOEs | | | | | | | | | | | Cash and cash equivalents | 4 | | | — | | | — | | | — | | | 4 | | | | | | | | | | | | Other investments(1) | — | | | — | | | — | | | 47 | | | 47 | | | | | | | | | | | | | Total assets | $ | 120 | | | $ | 1,350 | | | $ | 43 | | | $ | 3,189 | | | $ | 4,702 | | | Liabilities | | | | | | | | | | | VIEs | | | | | | | | | | | CLO notes | $ | — | | | $ | 1,134 | | | $ | — | | | $ | — | | | $ | 1,134 | | | Total liabilities | $ | — | | | $ | 1,134 | | | $ | — | | | $ | — | | | $ | 1,134 | | |
|
| Financial Instruments Not Carried at Fair Value |
The following table presents the classification of financial instruments which are not carried at fair value on the Condensed Consolidated Balance Sheets: | | | | | | | Financial Instrument | Classification | | Mortgage loans on real estate | Level 3 | | Policy loans | Level 2 | | | | | | Other investments | Level 2 | | Funding agreements without fixed maturities and deferred annuities | Level 3 | | Funding agreements with fixed maturities | Level 2 | | Supplementary contracts and immediate annuities | Level 3 | | Short-term debt and Long-term debt | Level 2 | | | | | | |
|